By continuing to use the site you agree to our Privacy & Cookies policy

Cancer drug recalled

The Medicine and Healthcare Products Regulatory Agency has warned patients taking the brain cancer drug temozolomide that some capsules could be in danger of splitting.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units